Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Surveillance Snapshot: Cervical Cancer Screening Among U.S. Military Service Women in the Millennium Cohort Study, 2003–2015

Image of Lt. Cmdr. Leslye Green, staff obstetrician and gynecologist, Naval Hospital Pensacola (NHP), uses a model to discuss cervical cancer with a patient at NHP. According to the Centers for Disease Control and Prevention (CDC), cervical cancer is highly preventable because screening tests for cervical cancer and vaccines to protect against human papillomavirus (HPV), which is the main cause of cervical cancer, are readily available. Cervical cancer is highly treatable and associated with long survival and good quality of life when it is detected early. (U.S. Navy photo by Mass Communication Specialist 1st Class Brannon Deugan). Lt. Cmdr. Leslye Green, staff obstetrician and gynecologist, Naval Hospital Pensacola (NHP), uses a model to discuss cervical cancer with a patient at NHP. According to the Centers for Disease Control and Prevention (CDC), cervical cancer is highly preventable because screening tests for cervical cancer and vaccines to protect against human papillomavirus (HPV), which is the main cause of cervical cancer, are readily available. Cervical cancer is highly treatable and associated with long survival and good quality of life when it is detected early. (U.S. Navy photo by Mass Communication Specialist 1st Class Brannon Deugan)

The Millennium Cohort Study is a prospective study that was initiated in 2001 and includes over 200,000 current and prior U.S. military service members.1 Questionnaires are sent to participants approximately every 3 years to collect information on service related experiences as well as mental, physical, and behavioral health. Compliance with contemporary cervical cancer screening recommendations was determined among service women enrolled in the Millennium Cohort Study during 2003–2015. Current cervical cancer screening recommendations call for a Pap smear alone every 3 years in women aged 21–65 years or for a human papillomavirus (HPV) DNA test with or without a Pap test every 5 years for women aged 30–65 years.2 Women were considered eligible for screening in a given year if they were aged 21–62 years on the last day of the year, had served in the active component (i.e., at least 9 months in active component pay and strength rosters) for the concurrent year and 2 years before, had not had a Click to closehysterectomyA partial or total surgical removal of the Click to closeuterusAlso known as the womb, the uterus is the female reproductive organ where a baby grows. uterus. It may also involve removal of the cervix, ovaries, Fallopian tubes, and other surrounding structures. hysterectomy, and had not separated from the military. Women were considered compliant with screening recommendations between 2003–2015 if they had a medical report of a Pap smear in the year of assessment or prior 2 calendar years. Women were also considered compliant with screening recommendations in 2013–2015 if they had HPV DNA testing completed within the previous 5 years.

Overall, among U.S. service women in the Millennium Cohort Study, the compliance rate increased from 61.2% in 2003 to a peak of 83.1% in 2010 then declined to a low of 59.8% in 2015 (Figure). During the first 7 years of the study period, compliance was highest among Air Force personnel. Between 2013 and 2015, compliance was highest among Coast Guard personnel. Compliance was lowest among Navy personnel in all but 1 year (2004) of the 13-year period. Compliance was also consistently higher for service women who had initiated the HPV vaccine than for women who had not (on average 6.3% higher). No differences in compliance were observed by cigarette smoking status, which was used as a surrogate measure of other health behaviors.

Author affiliations: Deployment Health Research Department in the Military Population Health Directorate, Naval Health Research Center, San Diego, CA (Dr. Matsuno, Dr. Porter, Mr. Warner, CAPT Wells); Leidos, San Diego, CA (Dr. Matsuno, Dr. Porter, Mr. Warner).

Disclaimer: One of the authors of this work is a military service member or employee of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C. §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. §101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties. This report was supported by the Military Operational Medicine Research Program under work unit no. 60002. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government.

 

References

Bulleted List for References

  1. Gray GC, Chesbrough KB, Ryan MA, et al. The Millennium Cohort Study: a 21-year prospective cohort study of 140,000 military personnel. Mil Med. 2002;167(6):483–488.
  2. U.S. Preventive Services Task Force. Final recommendation statement. Cervical cancer: screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening?ds=1&s=pap. Accessed 9 April 2020.

FIGURE. Cervical screening rates among service women, by branch of service, U.S. Armed Forces, 2003–2015

You also may be interested in...

Article
Mar 1, 2019

Brief Report: Male Infertility, Active Component, U.S. Armed Forces, 2013–2017

Sperm is the male reproductive cell  Photo: iStock

Infertility, defined as the inability to achieve a successful pregnancy after 1 year or more of unprotected sexual intercourse or therapeutic donor insemination, affects approximately 15% of all couples. Male infertility is diagnosed when, after testing both partners, reproductive problems have been found in the male. A male factor contributes in part ...

Article
Mar 1, 2019

Vasectomy and Vasectomy Reversals, Active Component, U.S. Armed Forces, 2000–2017

Sperm is the male reproductive cell  Photo: iStock

During 2000–2017, a total of 170,878 active component service members underwent a first-occurring vasectomy, for a crude overall incidence rate of 8.6 cases per 1,000 person-years (p-yrs). Among the men who underwent incident vasectomy, 2.2% had another vasectomy performed during the surveillance period. Compared to their respective counterparts, the ...

Article
Mar 1, 2019

Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2010–2018

Anopheles merus

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018. Infections with chlamydia were the most common, followed in decreasing order of frequency by infections with genital human papillomavirus (HPV), gonorrhea, genital herpes ...

Article
Mar 1, 2019

Testosterone Replacement Therapy Use Among Active Component Service Men, 2017

Image of Marines carrying a wooden log for physical fitness. Click to open a larger version of the image.

This analysis summarizes the prevalence of testosterone replacement therapy (TRT) during 2017 among active component service men by demographic and military characteristics. This analysis also determines the percentage of those receiving TRT in 2017 who had an indication for receiving TRT using the 2018 American Urological Association (AUA) clinical ...

Article
Feb 1, 2019

Update: Malaria, U.S. Armed Forces, 2018

Anopheles merus

Malaria infection remains an important health threat to U.S. service mem­bers who are located in endemic areas because of long-term duty assign­ments, participation in shorter-term contingency operations, or personal travel. In 2018, a total of 58 service members were diagnosed with or reported to have malaria. This represents a 65.7% increase from ...

Article
Feb 1, 2019

Update: Incidence of Glaucoma Diagnoses, Active Component, U.S. Armed Forces, 2013–2017

Glaucoma

Glaucoma is an eye disease that involves progressive optic nerve damage and vision loss, leading to blindness if undetected or untreated. This report describes an analysis using the Defense Medical Surveillance System to identify all active component service members with an incident diagnosis of glaucoma during the period between 2013 and 2017. The ...

Article
Feb 1, 2019

Re-evaluation of the MSMR Case Definition for Incident Cases of Malaria

Anopheles merus

The MSMR has been publishing the results of surveillance studies of malaria since 1995. The standard MSMR case definition uses Medical Event Reports and records of hospitalizations in counting cases of malaria. This report summarizes the performance of the standard MSMR case definition in estimating incident cases of malaria from 2015 through 2017. ...

Article
Feb 1, 2019

Outbreak of Acute Respiratory Illness Associated with Adenovirus Type 4 at the U.S. Naval Academy, 2016

Malaria case definition

Human adenoviruses (HAdVs) are known to cause respiratory illness outbreaks at basic military training (BMT) sites. HAdV type-4 and -7 vaccines are routinely administered at enlisted BMT sites, but not at military academies. During Aug.–Sept. 2016, U.S. Naval Academy clinical staff noted an increase in students presenting with acute respiratory ...

Article
Dec 1, 2018

Adrenal Gland Disorders, Active Component, U.S. Armed Forces, 2002–2017

During 2002–2017, the most common incident adrenal gland disorder among male and female service members was adrenal insufficiency and the least common was adrenomedullary hyperfunction. Adrenal insufficiency was diagnosed among 267 females (crude overall incidence rate: 8.2 cases per 100,000 person-years [p-yrs]) and 729 males (3.9 per 100,000 p-yrs). ...

Article
Dec 1, 2018

Incidence and Prevalence of the Metabolic Syndrome Using ICD-9 and ICD-10 Diagnostic Codes, Active Component, U.S. Armed Forces, 2002–2017

This report uses ICD-9 and ICD-10 codes (277.7 and E88.81, respectively) for the metabolic syndrome (MetS) to summarize trends in the incidence and prevalence of this condition among active component members of the U.S. Armed Forces between 2002 and 2017. During this period, the crude overall incidence rate of MetS was 7.5 cases per 100,000 person ...

Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery